flucytosine has been researched along with Shock, Cardiogenic in 2 studies
Flucytosine: A fluorinated cytosine analog that is used as an antifungal agent.
flucytosine : An organofluorine compound that is cytosine that is substituted at position 5 by a fluorine. A prodrug for the antifungal 5-fluorouracil, it is used for the treatment of systemic fungal infections.
Shock, Cardiogenic: Shock resulting from diminution of cardiac output in heart disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiron, LM | 1 |
| Pihet, M | 1 |
| Rouleau, F | 1 |
| de Gentile, L | 1 |
| Bouchara, JP | 1 |
| Chabasse, D | 1 |
| Vricella, LA | 1 |
| Khambadkone, S | 1 |
| Yates, R | 1 |
| Tsang, VT | 1 |
2 other studies available for flucytosine and Shock, Cardiogenic
| Article | Year |
|---|---|
[Comment on this case report].
Topics: Adult; Amphotericin B; Antifungal Agents; Buprenorphine; Candidiasis; Endocarditis; Endophthalmitis; | 2012 |
Right ventricular inflow obstruction from massive fungal vegetation presenting as neonatal circulatory collapse.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cardiopulmonary Bypass; Ductus Arteriosus, Patent; E | 2003 |